Six volunteers received an experimental pandemic influenza vaccine in the China-Japan Friendship Hospital yesterday in Beijing.
The vaccine is an inactivated sample of the H5N1 strain of bird flu. The volunteers, the first batch of 120 approved for clinical study of the vaccine, reported no adverse reactions within 30 minutes of the inoculation. The experiments will last nine months.